• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大35至54岁女性宫颈癌发病率上升:1992年至2022年加拿大特定年龄段宫颈癌发病率趋势

Increasing Cervical Cancer Rates Among Women Age 35-54 Years in Canada: Age-Specific Cervical Cancer Incidence Trends in Canada, 1992-2022.

作者信息

Nicolau Ioana A, Warkentin Matthew T, Graff Kirk, Doll Corinne, Bryant Heather, Brenner Darren R

机构信息

Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

出版信息

JCO Oncol Adv. 2025 Jul 9;2(1):e2400101. doi: 10.1200/OA-24-00101. eCollection 2025.

DOI:10.1200/OA-24-00101
PMID:40667567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12258797/
Abstract

PURPOSE

The vast majority of cervical cancer is preventable through human papillomavirus vaccination and screening with cytology or DNA testing. After decades of progress, recent cervical cancer trends in Western populations show a plateau or modest increase in incidence rates. Further investigation is required to understand the drivers of these emerging trends. In this study, we examined age-specific cervical cancer incidence rates in Canada from 1992 to 2022.

METHODS

Data were obtained from the Canadian Cancer Registry maintained by Statistics Canada, which included cancer cases, population counts, and incidence rates of cervical cancer by age and province for the period 1992 to 2022. Joinpoint regression analysis was used to estimate temporal incidence trends across age groups.

RESULTS

Cervical cancer incidence rates in Canada decreased among women age 25-34 years and those 65 years and older since 1992. Incidence rates among women age 35-44 years and 45-54 years have increased by 1.1% (95% CI, 0.5 to 2.5) and 1.6% (95% CI, -0.1 to 8.6) per year since 2001 and 2012, respectively. In 2022, the highest incidence rate of cervical cancer was among women age 35-44 years (18.1 per 100,000 women), which is comparable with rates in 1992.

CONCLUSION

Cervical cancer incidence rates have been increasing in recent years among women age 35-54 years. This cohort may be falling into a cancer prevention gap. Targeted public health interventions are warranted to address the rising incidence of cervical cancer among this cohort of Canadian women.

摘要

目的

通过人乳头瘤病毒疫苗接种以及细胞学或DNA检测筛查,绝大多数宫颈癌是可预防的。经过数十年的进展,西方人群近期的宫颈癌发病趋势显示发病率趋于平稳或略有上升。需要进一步调查以了解这些新趋势的驱动因素。在本研究中,我们调查了1992年至2022年加拿大特定年龄组的宫颈癌发病率。

方法

数据来自加拿大统计局维护的加拿大癌症登记处,其中包括1992年至2022年期间的癌症病例、人口计数以及按年龄和省份划分的宫颈癌发病率。采用Joinpoint回归分析来估计各年龄组的时间发病趋势。

结果

自1992年以来,加拿大25至34岁以及65岁及以上女性的宫颈癌发病率有所下降。自2001年和2012年以来,35至44岁以及45至54岁女性的发病率分别以每年1.1%(95%置信区间,0.5至2.5)和1.6%(95%置信区间,-0.1至8.6)的速度上升。2022年,宫颈癌发病率最高的是35至44岁的女性(每10万名女性中有18.1例),这与1992年的发病率相当。

结论

近年来,35至54岁女性的宫颈癌发病率一直在上升。这一年龄组可能正陷入癌症预防缺口。有必要采取有针对性 的公共卫生干预措施,以应对加拿大这一年龄组女性中不断上升的宫颈癌发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/12258797/b113d83ffd1d/oa-2-e2400101-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/12258797/b113d83ffd1d/oa-2-e2400101-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/12258797/b113d83ffd1d/oa-2-e2400101-g001.jpg

相似文献

1
Increasing Cervical Cancer Rates Among Women Age 35-54 Years in Canada: Age-Specific Cervical Cancer Incidence Trends in Canada, 1992-2022.加拿大35至54岁女性宫颈癌发病率上升:1992年至2022年加拿大特定年龄段宫颈癌发病率趋势
JCO Oncol Adv. 2025 Jul 9;2(1):e2400101. doi: 10.1200/OA-24-00101. eCollection 2025.
2
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
3
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.人乳头瘤病毒基因分型检测在日本女性自行采集的尿液和阴道样本癌症筛查中的效用
Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7.
4
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
5
Are There Sex Differences in the Association of Alcohol Consumption With the Risk of Soft Tissue Sarcoma? A Nationwide Population-based Study in Korea.饮酒与软组织肉瘤风险之间的关联存在性别差异吗?韩国一项基于全国人口的研究。
Clin Orthop Relat Res. 2025 Jun 25. doi: 10.1097/CORR.0000000000003602.
6
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
7
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in Canada.加拿大艾滋病毒-丙型肝炎病毒合并感染患者中丙型肝炎病毒消除进展情况。
Can Liver J. 2025 Feb 25;8(1):49-62. doi: 10.3138/canlivj-2024-0042. eCollection 2025 Feb.
10
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.

本文引用的文献

1
Progress and Challenges in Canada's Path Toward the Elimination of Cervical Cancer.加拿大消除宫颈癌道路上的进展与挑战。
Curr Oncol. 2024 Sep 29;31(10):5850-5861. doi: 10.3390/curroncol31100435.
2
Strategies to accelerate the elimination of cervical cancer in British Columbia, Canada: a modelling study.在加拿大不列颠哥伦比亚省加速消除宫颈癌的策略:一项建模研究。
CMAJ. 2024 Jun 2;196(21):E716-E723. doi: 10.1503/cmaj.231682.
3
Projected estimates of cancer in Canada in 2024.2024 年加拿大癌症预估。
CMAJ. 2024 May 12;196(18):E615-E623. doi: 10.1503/cmaj.240095.
4
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
5
Progress in site-specific cancer mortality in Canada over the last 70 years.加拿大过去 70 年来特定部位癌症死亡率的变化。
Sci Rep. 2024 Mar 7;14(1):5688. doi: 10.1038/s41598-024-56150-x.
6
Age-Specific Trends of Invasive Cervical Cancer Incidence in British Columbia, Canada, 1971-2017.加拿大不列颠哥伦比亚省 1971-2017 年浸润性宫颈癌发病率的年龄趋势。
Curr Oncol. 2023 Aug 18;30(8):7692-7705. doi: 10.3390/curroncol30080557.
7
Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.加拿大范围内关于 COVID-19 大流行对宫颈癌筛查和管理影响的调查:对卫生保健专业人员的横断面调查。
Elife. 2023 Jun 28;12:e83764. doi: 10.7554/eLife.83764.
8
Cervical Cancer Incidence Among US Women, 2001-2019.2001 - 2019年美国女性宫颈癌发病率
JAMA. 2022 Dec 13;328(22):2267-2269. doi: 10.1001/jama.2022.17806.
9
The increasing incidence of stage IV cervical cancer in the USA: what factors are related?美国IV期宫颈癌发病率上升:与哪些因素有关?
Int J Gynecol Cancer. 2022 Sep 6;32(9):1115-1122. doi: 10.1136/ijgc-2022-003728.
10
Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province.评估 COVID-19 大流行对加拿大中部一省癌症筛查的影响。
Prev Med. 2022 Feb;155:106961. doi: 10.1016/j.ypmed.2022.106961. Epub 2022 Jan 19.